Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation

Neoplasia

Volumn 2, Issue 1-2, 2000, Pages 53-61

  Vajkoczy, Peter ^a   Ullrich, Axel ^b   Menger, Michael D ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Cranial window; Dorsal skinfold chamber; In vivo; Perfusion; Vascularization

Indexed keywords

ACRIDINE ORANGE; DNA; FIBROBLAST GROWTH FACTOR 2; GREEN FLUORESCENT PROTEIN; IODOPHENAZONE C 14; RHODAMINE 6G; VASCULOTROPIN; XENON 133;

ANGIOGENESIS; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; IMAGING; LEUKOCYTE; METABOLISM; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; REVIEW; TUMOR VASCULARIZATION;

EID: 0034005797     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900062     Document Type: Review

References (107)

1. Folkman J (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285, 1182-1186.
2. Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1, 27-31.
3. Bedford JS, and Mitchell JB (1974). The effect of hypoxia on the growth and radiation response of mammalian cells in culture. Br J Radiol 47, 687-696.
4. Jones DP (1981). Hypoxia and drug metabolism. Biochem Pharmacol 30, 1019-1023.
5. Jain RK (1987). Transport of molecules in the tumor interstitium: a review. Cancer Res 47, 3039-3051.
6. Jain RK (1988). Determinants of tumor blood flow: a review. Cancer Res 48, 2641-2658.
7. Menger MD, and Lehr HA (1993). Scope and perspectives of intravital microscopy - bridge over from in vitro to in vivo. Immunol Today 14, 519-522.
8. Sandison JC (1924). A new method for the microscopic study of living growing tissue by the introduction of a transparent chamber in the rabbit's ear. Anat Rec 28, 281-287.
9. Ide AG, Baker NH, and Warren SL (1939). Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am J Roentgenol 42, 891-899.
10. Algire GH (1943). An adaption of the transparent chamber technique to the mouse. J Natl Cancer Inst USA 4, 1-11.
11. Algire GH, and Chalkley HW (1945). Vascular reactions of normal and malignant tissues in vivo: I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst USA 6, 73-85.
12. Papenfuss HD, Gross JF, Intaglietta M, and Treese FA (1979). A transparent access chamber for the rat dorsal skin fold. Microvasc Res 18, 311-318.
13. Endrich B, Asaishi K, Gotz A, and Messmer K (1980). Technical report - a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berlin) 177, 125-134.
14. Dewhirst MW, Tso CY, Oliver R, Gustafson CS, Secomb TW, and Gross JF (1989). Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Phys 17, 91-99.
15. Axelsson H, Bagge U, Lundholm K, and Svanberg E (1997). A one-piece plexiglass access chamber for subcutaneous implantation in the dorsal skin fold of the mouse. Int J Microcirc: Clin Exp 17, 328-329.
16. Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, and Jain RK (1992). Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res 52, 6553-6560.
17. Lehr HA, Leunig M, Menger MD, Nolte D, and Messmer K (1993). Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 143, 1055-1062.
18. Unterberg A, Wahl M, and Baethmann A (1984). Effects of bradykinin on permeability and diameter of pial vessels in vivo. J Cereb Blood Flow Metab 4, 574-585.
19. Rovainen CM, Woolsey TA, Blocher NC, Wang DB, and Robinson OF (1993). Blood flow in single surface arterioles and venules on the mouse somatosensory cortex measured with videomicroscopy, fluorescent dextrans, nonoccluding fluorescent beads, and computer-assisted image analysis. J Cereb Blood Flow Metab 13, 359-371.
20. Ishikawa M, Sekizuka E, Sato S, Yamaguchi N, Shimizu K, Kobayashi K, Bertalanffy H, and Kawase T (1999). In vivo rat closed spinal window for spinal microcirculation: observation of pial vessels, leukocyte adhesion, and red blood cell velocity. Neurosurgery 44, 156-161.
21. Tillmanns H, Ikeda S, and Bing RJ (1974). The effects of nicotine on the coronary microcirculation in the cat heart. J Clin Pharmacol 14, 426-433.
22. Kuhnle GE, Leipfinger FH, and Goetz AE (1993). Measurement of microhemodynamics in the ventilated rabbit lung by intravital fluorescence microscopy. J Appl Physiol 74, 1462-1471.
23. Menger MD, Marzi I, and Messmer K (1991). In vivo fluorescence microscopy for quantitative analysis of the hepatic microcirculation in hamsters and rats. Eur Surg Res 23, 158-169.
24. Klar E, Endrich B, and Messmer K (1990). Microcirculation of the pancreas. A quantitative study of physiology and changes in pancreatitis. Int J Microcirc: Clin Exp 9, 85-101.
25. Bohlen HG, Henrich H, Gore RW, and Johnson PC (1978). Intestinal muscle and mucosal blood flow during direct sympathetic stimulation. Am J Physiol 235, H40-H45.
26. Steinhausen M, Zimmerhackl B, Thederan H, Dussel R, Parekh N, Esslinger HU, von Hagens G, Komitowski D, and Dallenbach FD (1981). Intraglomerular microcirculation: measurements of single glomerular loop flow in rats. Kidney Int 20, 230-239.
27. von Andrian UH (1996). Intravital microscopy of the peripheral lymph node microcirculation in mice. Microcirculation 3, 287-300.
28. Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, and von Andrian UH (1998). Hematopoletic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 188, 465-474.
29. Gerlowski LE, and Jain RK (1986). Microvascular permeability of normal and neoplastic tissues. Microvasc Res 31, 288-305.
30. Menger MD, Pelikan S, Steiner D, and Messmer K (1992). Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox." Am J Physiol 263, H1901-H1906.
31. Vajkoczy P, Menger MD, Simpson E, and Messmer K (1995). Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation 60, 123-127.
32. Vajkoczy P, Schilling L, Ullrich A, Schmiedek P, and Menger MD (1998). Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse. J Cereb Blood Flow Metab 18, 510-520.
33. Vajkoczy P, Menger MD, Vollmar B, Schilling L, Schmiedek P, Hirth KP, Ullrich A, and Fong TAT (1999). Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia 1, 31-41.
34. Vajkoczy P, Goldbrunner R, Farhadi M, Vince G, Schilling L, Tonn JC, Schmiedek P, and Menger MD (1999). Glioma cell migration is associated with glioma-induced angiogenesis in vivo. Int J Dev Neurosci, in press.
35. Saetzler RK, Jallo J, Lehr HA, Philips CM, Vasthare U, Arfors KE, and Tuma RF (1997). Intravital fluorescence microscopy: impact of light-induced phototoxicity on adhesion of fluorescently labeled leukocytes. J Histochem Cytochem 45, 505-513.
36. Vajkoczy P, Schilling L, Schmiedek P, and Menger MD (1997). Glioma angiogenesis and vascularization: significance of leukocyte/endothelium-interaction. J Cereb Blood Flow Metab 17 (suppl 1), S179.
37. Lehr HA, Vollmar B, Vajkoczy P, and Menger MD (1999). Intravital fluorescence microscopy for the study of leukocyte interaction with platelets and endothelial cells. Methods Enzymol 300, 462-481.
38. Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, and Messmer K (1998). Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92, 507-515.
39. Heim R, and Tsien RY (1996). Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 6, 178-182.
40. Contag PR, Olomu IN, Stevenson DK, and Contag CH (1998). Bioluminescent indicators in living mammals. Nat Med 4, 245-247.
41. Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, and Burger PC (1994). Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg 81, 902-909.
42. Orita T, Nishizaki T, Kamiryo T, Aoki H, Harada K, and Okamura T (1988). The microvascular architecture of human malignant glioma. A scanning electron microscopic study of a vascular cast. Acta Neuropathol (Berlin) 76, 270-274.
43. Konerding MA, Steinberg F, and Budach V (1989). The vascular system of xenotransplanted tumors - scanning electron and light microscopic studies. Scanning Microsc 3, 327-335.
44. Bernsen HJ, Rijken PF, Oostendorp T, and van der Kogel AJ (1995). Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. Br J Cancer 71, 721-726.
45. Whittle IR, Collins F, Kelly PA, Ritchie I, and Ironside JW (1996). Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow. Acta Neurochir (Wien) 138, 870-875.
46. Andrade SP, Hart IR, and Piper PJ (1992). Inhibitors of nitric oxide synthase selectively reduce flow in tumor - associated neovasculature. Br J Pharmacol 107, 1092-1095.
47. Foltz RM, McLendon RE, Friedman HS, Dodge RK, Bigner DD, and Dewhirst MW (1995). A pial window model for the intracranial study of human glioma microvascular function. Neurosurgery 36, 976-984.
48. Intaglietta M, and Zweifach BW (1974). Microcirculatory basis of fluid exchange. Adv Biol Med Phys 15, 111-159.
49. Vollmar B, Glasz J, Leiderer R, Post S, and Menger MD (1994). Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145, 1421-1431.
50. Kan Z, Ivancev K, Lunderquist A, McCuskey PA, Wright KC, Wallace S, and McCuskey RS (1993). In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 187, 621-626.
51. Fukumura D, Yuan F, Monsky WL, Chen Y, and Jain RK (1997). Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151, 679-688.
52. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, and Groom AC (1998). Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153, 865-873.
53. Naumov GN, Wilson SM, MacDonald IC, Schmidt EE, Morris VL, Groom AC, Hoffman RM, and Chambers AF (1999). Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 112, 1835-1842.
54. Borgstrom P, Hillan KJ, Sriramarao P, and Ferrara N (1996). Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56, 4032-4039.
55. Jain RK, Safabakhsh N, Sckell A, Chen Y, Jiang P, Benjamin L, Yuan F, and Keshet E (1998). Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci USA 95, 10820-10825.
56. Borgstrom P, Bourdon MA, Hillan KJ, Sriramarao P, and Ferrara N (1998). Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35, 1-10.
57. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, and Jain RK (1994). Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54, 4564-4568.
58. Coomber BL, Stewart PA, Hayakawa EM, Farrell CL, and Del Maestro RF (1988). A quantitative assessment of microvessel ultrastructure in C6 astrocytoma spheroids transplanted to brain and to muscle. J Neuropathol Exp Neurol 47, 29-40.
59. Konerding MA, Malkusch W, Klapthor B, van Ackern C, Fait E, Hill SA, Parkins C, Chaplin DJ, Presta M, and Denekamp J (1999). Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer 80, 724-732.
60. Falk P (1982). Differences in vascular pattern between the spontaneous and the transplanted C3H mouse mammary carcinoma. Eur J Cancer Clin Oncol 18, 155-165.
61. Field SB, Needham S, Burney IA, Maxwell RJ, Coggle JE, and Griffiths JR (1991). Differences in vascular response between primary and transplanted tumours. Br J Cancer 63, 723-726.
62. Bergers G, Hanahan D, and Coussens LM (1998). Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol 42, 995-1002.
63. Dirnagl U, Villringer A, and Einhaupl KM (1992). In vivo confocal scanning laser microscopy of the cerebral microcirculation. J Microsc 165, 147-157.
64. Kleinfeld D, Mitra PP, Helmchen F, and Denk W (1998). Fluctuations and stimulus-induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc Natl Acad Sci USA 95, 15741-15746.
65. Dellian M, Witwer BP, Salehi HA, Yuan F, and Jain RK (1996). Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 149, 59-71.
66. Baish JW, and Jain RK (1998). Cancer, angiogenesis and fractals. Nat Med 4, 984.
67. Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M, and Alitalo K (1995). Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146, 368-378.
68. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, and Wiegand SJ (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998.
69. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, and Seed B (1998). Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715-725.
70. Endrich B, Intaglietta M, Reinhold HS, and Gross JF (1979). Hemodynamic characteristics in microcirculatory blood channels during early tumor growth. Cancer Res 39, 17-23.
71. Yuan F, Leunig M, Berk DA, and Jain RK (1993). Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 45, 269-289.
72. Vollmar B, Wolf B, Siegmund S, Katsen AD, and Menger MD (1997). Lymph vessel expansion and function in the development of hepatic fibrosis and cirrhosis. Am J Pathol 151, 169-175.
73. Baish JW, Gazit Y, Berk DA, Nozue M, Baxter LT, and Jain RK (1996). Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc Res 51, 327-346.
74. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, and Folkman J (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
75. Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth KP, and McMahon G (1999). SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 59, 99-106.
76. Huang X, Molema G, King S, Watkins L, Edgington TS, and Thorpe PE (1997). Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275, 547-550.
77. Pasqualini R (1999). Vascular targeting with phage peptide libraries. Q J Nucl Med 43, 159-162.
78. Tozer GM, Prise VE, Wilson J, Locke RJ, Vojnovic B, Stratford MR, Dennis MF, and Chaplin DJ (1999). Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Cancer Res 59, 1626-1634.
79. Asaishi K, Endrich B, Gotz A, and Messmer K (1981). Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3. Cancer Res 41, 1898-1904.
80. Skinner SA, Tutton PJ, and O'Brien PE (1990). Microvascular architecture of experimental colon tumors in the rat. Cancer Res 50, 2411-2417.
81. Less JR, Posner MC, Skalak TC, Wolmark N, and Jain RK (1997). Geometric resistance and microvascular network architecture of human colorectal carcinoma. Microcirculation 4, 25-33.
82. Konerding MA, Fait E, Dimitropoulou C, Malkusch W, Ferri C, Giavazzi R, Coltrini D, and Presta M (1998). Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. Am J Pathol 152, 1607-1616.
83. Secomb TW, Hsu R, Dewhirst MW, Klitzman B, and Gross JF (1993). Analysis of oxygen transport to tumor tissue by microvascular networks. Int J Radiat Oncol Biol Phys 25, 481-489.
84. Hirano A, and Matsui T (1975). Vascular structures in brain tumors. Hum Pathol 6, 611-621.
85. Waggener JD, and Beggs JL (1976). Vasculature of neural neoplasms. Adv Neurol 15, 27-49.
86. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, and Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
87. Peterson HI, Alpsten M, Skolnik G, and Karlsson L (1985). Influence of a prostaglandin synthesis inhibitor and of thrombocytopenia on tumor blood flow and tumor vascular permeability. Experimental studies in the rat. Anticancer Res 5, 253-257.
88. Sands H, Jones PL, Shah SA, Palme D, Vessella RL, and Gallagher BM (1988). Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts. Cancer Res 48, 188-193.
89. Nugent LJ, and Jain RK (1982). Monitoring transport in the rabbit ear chamber. Microvasc Res 24, 204-209.
90. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, and Jain RK (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55, 3752-3756.
91. Chary SR, and Jain RK (1989). Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci USA 86, 5385-5389.
92. Berk DA, Yuan F, Leunig M, and Jain RK (1997). Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc Natl Acad Sci USA 94, 1785-1790.
93. von Andrian UH, and Arfors KE (1993). Neutrophil-endothelial cell interactions in vivo: a chain of events characterized by distinct molecular mechanisms. Agents Actions Suppl 41, 153-164.
94. Springer TA (1995). Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57, 827-872.
95. Menger MD, and Vollmar B (1996). Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg 83, 588-601.
96. Fukumura D, Salehi HA, Witwer B, Tuma RF, Melder RJ, and Jain RK (1995). Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res 55, 4824-4829.
97. Jain RK, Koenig GC, Dellian M, Fukumura D, Munn LL, and Melder RJ (1996). Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev 15, 195-204.
98. Morioka T, Baba T, Black KL, and Streit WJ (1992). Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. Neurosurgery 30, 891-896.
99. Suzuki Y, Ohtani H, Mizoi T, Takeha S, Shiiba K, Matsuno S, and Nagura H (1995). Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res 86, 585-593.
100. Engebraaten O, Bjerkvig R, Pedersen PH, and Laerum OD (1993). Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 53, 209-214.
101. Giese A, and Westphal M (1996). Glioma invasion in the central nervous system. Neurosurgery 39, 235-250.
102. Skobe M, Rockwell P, Goldstein N, Vosseler S, and Fusenig NE (1997). Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 3, 1222-1227.
103. Torres Filho IP, and Intaglietta M (1993). Microvessel PO2 measurements by phosphorescence decay method. Am J Physiol 265, H1434-H1438.
104. Chance B, Cohen P, Jöbsis F, and Schoener B (1962). Intracellular oxidation-reduction states in vivo. The microfluorometry of pyridine nucleotide gives a continuous measurement of the oxidation state. Science 137, 499-508.
105. Vollmar B, Burkhardt M, Minor T, Klauke H, and Menger MD (1997). High-resolution microscopic determination of hepatic NADH fluorescence for in vivo monitoring of tissue oxygenation during hemorrhagic shock and resuscitation. Microvasc Res 54, 164-173.
106. Helmlinger G, Yuan F, Dellian M, and Jain RK (1997). Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3, 177-182.
107. Suematsu M, Schmid-Schonbein GW, Chavez-Chavez RH, Yee TT, Tamatani T, Miyasaka M, Delano FA, and Zweifach BW (1993). In vivo visualization of oxidative changes in microvessels during neutrophil activation. Am J Physiol 264, H881-H891.